GSK Korea Marks 40th Anniversary with Employee Celebration

Society|
|
By Sung Hyung-joo
||
null - Seoul Economic Daily Society News from South Korea

GSK Korea held an employee celebration to mark its 40th anniversary on the 8th, the company said on the 9th.

The event focused on sharing a commitment to continuously strengthening patient-centered values amid a changing healthcare environment.

Founded in 1986, GSK Korea has contributed to the advancement of Korea's healthcare over the past 40 years by supplying innovative treatment options in vaccines and prescription medicines. Through a broad portfolio spanning vaccines, specialty medicines, and general medicine, the company currently addresses medical needs across the entire life cycle, from prevention to the treatment of chronic and severe diseases.

The photo shows Chief Executive Officer Guna Ryediger (fourth from left) and employees taking a commemorative photo. Photo courtesy of GSK Korea.

Original reporting by Sung Hyung-joo for Seoul Economic Daily.

AI-translated from Korean. Quotes from foreign sources are based on Korean-language reports and may not reflect exact original wording.

Watch · Seoul Economic Daily

More →
5:23

AI KEY

Preview
Korean Corporate Intelligence HubKOSPI · KOSDAQ · 12 sectors

A live, cap-weighted view of every KOSPI and KOSDAQ sector, with same-day Korean reporting distilled by company — built for foreign investors, correspondents and analysts who need to scan Korea before the next session.

Korea Chaebol Tree

Preview
Families Behind the GroupsKFTC May 2026 · DART filings

An English-first interactive map of Samsung, SK, Hyundai, LG and Lotte — built for foreign investors, correspondents and analysts. Korea translates companies into English. We translate the families behind them.

SIGNAL

Pre-register
English Edition · Capital MarketsM&A · IPO · PE · Fund Flows

Pre-register for SIGNAL English Edition — a premium subscription bringing Korean capital markets coverage (M&A, IPOs, private equity, fund flows) to global institutional investors. First access to the 50% introductory rate.